Prognostic implications of margin status in association with systemic treatment in a cohort study of patients with resection of colorectal liver metastases.

R1 is associated with worse outcomes in the patients who receive neoadjuvant treatment with no significant improvement with the addition of adjuvant therapy, likely representing an aggressive tumor biology. R1 did not impact OS in patients with upfront surgery who received postoperative chemotherapy.